Table 1.

Comparison of 980 patients with brucellosis who have or have not endured a relapse

		Number	(relapse)	Non (relapse)	P-value
Total		980	10.51%(103)	89.49%(877)
Male	Sex	570	10%(57)	90%(513)	.598
	Female	410	11.2%(46)	88.8%(364)
Age	<40	665	9.5%(63)	90.5%(602)	.147
	>40	315	12.7%(40)	87.3%(275)
Residency	Urban	561	11.8%(66)	88.2%(495)	.142
	Rural	419	8.8%(37)	91.2%(382)
Occupational exposure		427	9.4%(40)	90.6%(387)	.345
Delayed treatment	<2month	756	10.4%(79)	89.6%(677)	.8
	2month -1year	185	10.3%(19)	89.7%(166)
	>1year	39	12.8%(5)	87.2%(34)
Fever		574	9.5%(52)	90.5%(493)	.295
Chills		227	9.3%(21)	90.7%(206)	.538
Sweating		595	9.1%(54)	90.9%(541)	.071
Weakness		149	7.4%(11)	92.6%(138)	.194
Fatigue		123	8.1%(10)	91.9%(113)	.433
Anorexia		46	8.7%(4)	91.3%(42)	1
Nausea and vomiting		12	8.3%(1)	91.7%(11)	1
Diarrhea		5	20%(1)	80%(4)	.427
Myalgia		345	9.9%(34)	90.1%(311)	.664
Arthralgia		511	11.4%(58)	88.6%(453)	.405
Headache		90	6.7%(6)	93.3%(84)	.278
Abdominal pain		15	6.7%(1)	93.3%(14)	1
Back Pain		275	13.5%(37)	86.5%(238)	.64
sacralgia		36	13.9%(5)	86.1%(31)	.417
Sacroiliitis		75	9.3%(7)	90.7%(68)	.846
Arthritis		144	11.1%(16)	88.9%(128)	.77
Epididymo-orchitis		46	15.2%(7)	84.8%(39)	.319
Splenomegaly		55	5.5%(3)	94.5%(52)	.262
Skin lesion		10	10%(1)	90%(9)	1
Abortion		4	0%	100%(4)	1
Weight loss		73	6.8%(5)	93.2%(68)	.425
Lymphadenopathy		23	17.4%(4)	82.6%(19)	.291
Complications	Yes	260	11.2%(29)	88.8%(231)	.724
	No	720	10.3%(74)	89.7%(646)
Positive blood culture		5	0%	100%(5)	1
Wright test	< 1:640	503	9.6%(48)	90.4%(455)	.403
	> 1:640	477	11.3%(54)	88.7%(423)
Treatment regimen	No.1	181	14.4%(26)	85.6%(155)	0
	No.2	78	17.9%(14)	82.1%(64)
	No.3	343	5.5%(19)	94.5%(324)
	No.4	129	.8%(1)	99.2%(128)
	No.5	185	19.5%(36)	80.5%(149)
	No.6	64	10.9%(7)	89.1%(57)